| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| produit contenant du nitrate de pilocarpine |
Is a |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Pilocarpine adverse reaction |
Causative agent (attribute) |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Pilocarpine overdose |
Causative agent (attribute) |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Intentional pilocarpine overdose |
Causative agent (attribute) |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| surdose de pilocarpine d'intention indéterminée |
Causative agent (attribute) |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Pilocarpine hydrochloride (substance) |
Is a |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Pilocarpine nitrate (substance) |
Is a |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Product containing pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Physostigmine+pilocarpine 0.25%+2% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Physostigmine+pilocarpine 0.25%+4% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Physostigmine+pilocarpine 0.5%+4% eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Product containing physostigmine and pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Intentional pilocarpine poisoning |
Causative agent (attribute) |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to pilocarpine (finding) |
Causative agent (attribute) |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Poisoning by pilocarpine |
Causative agent (attribute) |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely pilocarpine 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Pilocarpine-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely pilocarpine 7.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Product containing pilocarpine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Accidental poisoning by pilocarpine |
Causative agent (attribute) |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Allergy to pilocarpine (finding) |
Causative agent (attribute) |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely pilocarpine 5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely pilocarpine 5 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely pilocarpine 7.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely pilocarpine 7.5 milligram/1 each conventional release oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/1%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/4%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/6%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Epinephrine bitartrate + pilocarpine hydrochloride 1%/2%wv solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Product containing epinephrine and pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Pilocarpine hydrochloride (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Pilocarpine nitrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
|
| Product containing precisely pilocarpine 5 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing precisely pilocarpine 7.5 milligram/1 each conventional release oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Pilocarpine-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only epinephrine and pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only physostigmine and pilocarpine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Pilocarpine only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only pilocarpine in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only pilocarpine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing physostigmine and pilocarpine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Product containing only physostigmine and pilocarpine in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
| Accidental pilocarpine overdose |
Causative agent (attribute) |
True |
Pilocarpine (substance) |
Inferred relationship |
Some |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]